374 filings
Page 7 of 19
4/A
Javitt Jonathan C
2 Jun 22
NRX Pharmaceuticals / Jonathan C Javitt ownership change
9:46am
4
Javitt Jonathan C
2 Jun 22
NRX Pharmaceuticals / Jonathan C Javitt ownership change
8:55am
424B3
NRXP
NRX Pharmaceuticals Inc
1 Jun 22
Prospectus supplement
4:01pm
424B3
NRXP
NRX Pharmaceuticals Inc
1 Jun 22
Prospectus supplement
4:01pm
424B3
NRXP
NRX Pharmaceuticals Inc
1 Jun 22
Prospectus supplement
4:01pm
8-K
NRXP
NRX Pharmaceuticals Inc
31 May 22
Other Events
4:37pm
8-K
NRXP
NRX Pharmaceuticals Inc
25 May 22
Departure of Directors or Certain Officers
5:18pm
424B3
NRXP
NRX Pharmaceuticals Inc
17 May 22
Prospectus supplement
9:33pm
10-Q
2022 Q1
NRXP
NRX Pharmaceuticals Inc
Quarterly report
16 May 22
4:08pm
424B5
NRXP
NRX Pharmaceuticals Inc
5 May 22
Prospectus supplement for primary offering
4:21pm
424B5
NRXP
NRX Pharmaceuticals Inc
5 May 22
Prospectus supplement for primary offering
4:19pm
EFFECT
NRXP
NRX Pharmaceuticals Inc
4 May 22
Notice of effectiveness
12:15am
EFFECT
NRXP
NRX Pharmaceuticals Inc
4 May 22
Notice of effectiveness
12:15am
POS AM
NRXP
NRX Pharmaceuticals Inc
29 Apr 22
Prospectus update (post-effective amendment)
4:08pm
POS AM
NRXP
NRX Pharmaceuticals Inc
29 Apr 22
Prospectus update (post-effective amendment)
4:05pm
10-K/A
2021 FY
NRXP
NRX Pharmaceuticals Inc
Annual report (amended)
29 Apr 22
4:01pm
424B3
NRXP
NRX Pharmaceuticals Inc
20 Apr 22
Prospectus supplement
9:27am
EFFECT
NRXP
NRX Pharmaceuticals Inc
20 Apr 22
Notice of effectiveness
12:15am
CORRESP
NRXP
NRX Pharmaceuticals Inc
18 Apr 22
Correspondence with SEC
12:00am
UPLOAD
NRXP
NRX Pharmaceuticals Inc
15 Apr 22
Letter from SEC
12:00am